A special recording procedure for certain securities will be in effect until the end of 2025

Learn more

Garant – Free Online Demo

Legal information system for your company.
Simply click on the button «Start working» and the system Legislation of Russia in English will be available for unlimited time.

News

23.03.2022
THE ANTIVIRAL DRUG REMDESIVIR FOR TREATMENT OF PATIENTS WITH COVID-19 WILL BE TEMPORARILY PRODUCED IN RUSSIA WITHOUT CONSENT OF AMERICAN PATENT HOLDERS
Until the end of 2022, JSC "R-Pharm" is allowed to produce the remdesivir without the consent of the American patent holders represented by Gilead Sciences, Inc. and Gilead Pharmasset LLC.
 

Archive

mon tue wed thu fri sat sun
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31

Contact Us

Leave us a message